ELI LILLY AND COMPANY |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 744.3 USD | +1.77% |
|
-0.17% | +27.88% |
| 05:55pm | Global markets live: Bayer, PepsiCo, Halliburton, Spotify, Apple... |  |
| 12:00pm | Alzheimer's drug adoption in US slowed by doctors' skepticism | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
Pharmaceuticals
Calendar
2024-04-30
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
731.3
USD
Average target price
813.3
USD
Spread / Average Target
+11.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +27.88% | 659B | |
| +27.68% | 557B | |
| -4.43% | 359B | |
| +16.46% | 322B | |
| +9.46% | 297B | |
| +6.30% | 215B | |
| +4.80% | 210B | |
| -6.05% | 200B | |
| -8.53% | 149B | |
| -5.01% | 146B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Insider Trends: Insider 90-Day Selling Trend Extended at Eli Lilly
